Fulcrum Pharmaceuticals LLC Accepts 11.6 Million Stage Takeover Bid

Reuters -- Fulcrum Pharma Plc said it accepted a 11.6 million pounds ($17.69 million) takeover bid by a company funded by venture capital group SV Life Sciences and private equity firm Halifax Group, sending its shares up 66.7 percent.